Parathyroid Hormone (Human, 1-84)

<strong>Parathyroid Hormone (Human, 1-84)</strong>_x000D_ <strong>Catalog number:</strong> MDP0504_x000D_ <strong>CAS Number: </strong>133448-20-1_x000D_ <strong>Sequence: </strong>Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln_x000D_ <strong>Amount:</strong> 20 mg_x000D_ <strong>Molecular Weight:</strong> 9424.4 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 ¬∞C_x000D_ <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals._x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kim ES, Keating GM. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism Drugs. 2015 Jul;75(11):1293-303._x000D_ 2: Hawkes CP, Shulman DI, Levine MA. Recombinant human parathyroid hormone (1-84) is effective in CASR-associated hypoparathyroidism Eur J Endocrinol. 2020 Dec;183(6):K13-K21._x000D_ 3: Lakatos P, Bajnok L, Lagast H, Valkusz Z. AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM Endocr Pract. 2016 May;22(5):523-32._x000D_ 4: Liu Q, Lin J, Liu M, Tao X, Wei D, Ma X, Yang S. Large scale preparation of recombinant human parathyroid hormone 1-84 from Escherichia coli Protein Expr Purif. 2007 Aug;54(2):212-9._x000D_ 5: Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study Lancet Diabetes Endocrinol. 2013 Dec;1(4):275-83._x000D_ 6: Gruson D. PTH and cardiovascular risk Ann Endocrinol (Paris). 2021 Jun;82(3-4):149-150._x000D_ 7: Tabacco G, Bilezikian JP. New Directions in Treatment of Hypoparathyroidism Endocrinol Metab Clin North Am. 2018 Dec;47(4):901-915._x000D_ 8: Vokes TJ, Mannstadt M, Levine MA, Clarke BL, Lakatos P, Chen K, Piccolo R, Krasner A, Shoback DM, Bilezikian JP. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism J Clin Endocrinol Metab. 2018 Feb 1;103(2):722-731._x000D_ 9: Guo QR, Wei DZ, Tong WY. Partial purification of human parathyroid hormone 1-84 as a thioredoxin fusion form in recombinant Escherichia coli by thermoosmotic shock Protein Expr Purif. 2006 Sep;49(1):32-8._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/28942334">10: Bilezikian JP, Clarke BL, Mannstadt M, Rothman J, Vokes T, Lee HM, Krasner A. Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-µg or 50-µg Daily Doses Clin Ther. 2017 Oct;39(10):2096-2102. </a>_x000D_ _x000D_ <strong>Products Related to Parathyroid Hormone (Human, 1-84) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>